Le Lézard
Classified in: Health, Science and technology, Business
Subject: BFA

GC Incentives Partners with CoreHealth Technologies to Deliver Wellness Rewards Globally


OMAHA, Neb., Nov. 28, 2017 /PRNewswire-USNewswire/ -- GC Incentives continues to expand its global reach in the incentives and recognition industry, including wellness rewards, through its new partnership with CoreHealth Technologies, a wellness technology company.

GC Incentives will leverage its experience and global partnership with UK-based Ovation Incentives to simplify the administration and fulfillment of wellness rewards for global customers on the CoreHealth corporate wellness portal.

"Our technology powers wellness programs for health providers, and their global clients, located around the world. These providers are looking for a one-stop solution that makes it easy to incent and reward employees for their participation and success in wellness programs ? no matter where they are located in the world," says Anne Marie Kirby, CEO of CoreHealth Technologies. "With GC Incentives, we found a perfect partner to help us deliver a seamless wellness rewards solution to customers."    

Rick Buer, CEO of GC Incentives, said the new agreement expands GC's focus in the health and wellness market and adds value to robust reward systems like CoreHealth's. CoreHealth customers can further maximize their investment in the platform by easily adding gift card wellness incentives in over 35 languages and 120-plus countries from more than 1,200 gift card brands globally. Points earned on the CoreHealth platform are instantly converted to tangible, fun rewards.

"We're excited to partner with CoreHealth to integrate our rewards capabilities and collectively bring a solution to organizations that rewards healthy behaviors and makes a positive impact on individuals and their corporations," said Buer.

While CoreHealth Technologies works with numerous best-in-class health and wellness vendors to deliver value-add programs and services to customers, GC Incentives is the first partner to offer gift card wellness rewards to CoreHealth customers.

CoreHealth's all-in-one wellness technology powers wellness programs for corporate wellness companies, insurers and their wellness divisions, health coaching companies, employee assistance providers, group benefits brokers, and human resources consulting firms.

GC Incentives, with its game-changing digital wallet technology, gives participants the opportunity to earn as they go, with gift card rewards that never expire.

The simple, seamless integration of both CoreHealth and GC Incentives technologies enable customers to maintain their corporate branding throughout both platforms.

Media contacts:

For GC Incentives
Sue Voyles, Logos Communications, [email protected], 734-667-2005

For CoreHealth Technologies
Anne Marie Kirby, CEO, 250-448-5306 x101

 

SOURCE GC Incentives


These press releases may also interest you

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...

at 02:00
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

at 01:00
REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the annual and the extraordinary shareholders'...

at 00:16
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA...

at 00:00
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101...



News published on and distributed by: